Allogene Therapeutics ALLO
NASDAQ ALLO
$0.90 -0.03 (-3.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Allogene Therapeutics (ALLO) Other financing activities (as filed) (2025)

Updated

Allogene Therapeutics (ALLO) reported Other financing activities of $6.91 million for FY2025, up 203.0% from $2.28 million in FY2024.

Analysis

Allogene Therapeutics (ALLO) Other financing activities (as filed) (2025) Analysis & Trends

  • According to Business Quant data, Other financing activities came in at $2.28 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Allogene Therapeutics 322.04 Mn -820.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3.56 Mn
Mar 31, 2025 3.35 Mn
API Access

Allogene Therapeutics Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ALLO&period=max&api_key=YOUR_API_KEY